Want smooth, stress-free skin? Bellafill® is the answer. The first and only FDA approved long-lasting Acne Scarring Treatment is here. Bellafill® is ideal for ALL skin types, textures, and colors. Learn more about Bellafill® below and see why we’re obsessed (you will be too).
Bellafill® Acne is a FDA approved collagen-based injectable for the treatment of certain types of acne scars. Bellafill® adds instant volume to the scarred area, leveling the skin’s surface and smoothing it’s texture. Bellafill® is composed of 80% Collagen Gel and 20% Polymethyl Methacrylate (PMMA) microspheres.
The collagen is the smooth base of the filler which immediately adds volume to the depressed scar raising it to a level that’s even with the surrounding skin. Then, the PMMA microspheres form a supportive scaffold that helps support the growth of your body’s own natural collagen to supplant for long-lasting results. As the gel breaks down over time, your own collagen forms a foundation that adds volume, filling in the acne scars providing a sustained improvement that is long-lasting.
Truly a unique treatment for Acne Scar Treatment, Bellafill® is safe and effective on all skin types, colors, and textures. Why is this unique? Most scarring treatments are not safe to use on darker skin tones (deep chemical peels and laser treatments) and others can become costly (years worth of laser, chemical peels, and makeup). Bellafill® is safe, effective, and affordable. Bellafill® is approved for use on men and women, 21 and older. It works on distensible and atrophic acne scars on the cheeks. Distensible scars smooth out when you tug on them, atrophic scars are pitted or depressed in the skin.
A pivotal, randomized, double-blinded, placebo-controlled study was conducted to evaluate the effectiveness and safety of Bellafill® for treating moderate to severe, atrophic, distensible facial acne scars on the cheek. Subjects were randomized to Bellafill® vs. saline injections. Bellafill® was found to be a safe and effective treatment when compared to Control treated subjects.
This study maintained a high threshold for success: the primary effectiveness endpoint defined a responder as a subject who had 50 percent or more of treated acne scars, improve by two or more points on a validated 4-point Acne Scar Rating Scale (ASRS). This six month endpoint was met with statistical significance and, as a secondary endpoint, continued to show improvement at nine and 12 months when assessed by the un-blinded investigator. Subjects blinded to treatment also reported successful outcomes and demonstrated improvement in their global appearance after treatment with Bellafill®.
Both collagen and PMMA have established safety records and have been used in other areas of medicine, such as orthopedic surgery, dentistry, and ophthalmology. All patients must receive an allergy skin test 4 weeks prior to treatment (this is done in office 24 hours before treatment and administer to detect a potential allergy to the collagen or lidocaine). Most patients need/ use only 1 syringe for treatment.
Topical treatments, chemical peels, dermabrasion, microneedling, and laser resurfacing are among the current available treatment options for acne scars. However, some of these treatments may require significant downtime. In some cases, results can take time to emerge — and other treatments often lack rigorous, controlled data to support their safety or efficacy.
Bellafill® is the only filler that’s approved by the FDA to treat acne scars, providing an entirely new treatment choice for patients. No other dermal filler on the market is approved for the treatment of acne scars.
Yes. Bellafill® is the only FDA-approved dermal filler for the correction of moderate to severe atrophic, distensible facial acne scars on the cheeks in patients 21 and over. Bellafill® has been proven to provide both immediate and lasting results in rigorous clinical studies, with demonstrated effectiveness, safety, and high rates of patient satisfaction.
As with many injectable fillers, you may experience bruising, itchiness, pain, swelling, redness, discoloration, lumpiness, bumps, acne, or increased sensitivity at the treatment site. These side effects usually go away by themselves within a few days.
No, Bellafill® is the only FDA-approved dermal filler, on the market, for the correction of atrophic (pitted), distensible facial acne scars on the cheeks. No other dermal filler on the market is approved for the treatment of acne scars.
In a clinical study on acne scarring, Bellafill® remained safe and effective for patients through twelve months. In a separate clinical study on smoothing out nasolabial folds (smile lines), its safety and effectiveness was established through five years. Your individual treatment plan will take these findings into account and develop a schedule that works best for you.
Bellafill® is the only dermal filler FDA approved for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years. It is also the only dermal filler established safe and effective for nasolabial fold correction through 5 years.
Satisfaction and effectiveness for the correction of nasolabial folds have been established through 5 years. Effectiveness for the correction of acne scars has been proven through 12 months.
Yes. Millions of Americans suffer from acne and billions of dollars are spent each year on treatments. Furthermore, a significant number of acne sufferers go on to develop devastating scarring. With relatively low satisfaction with many available treatments with patients having to make trade-offs between efficacy, longevity, safety, downtime, and cost Bellafill® is a game changer. Acne scar sufferers have a new treatment choice that is proven to be safe and effective with minimal to no downtime.
Acne is the most common skin disorder in the U.S., affecting up to 40–50 million Americans. A significant number of acne sufferers go on to develop devastating scarring. Scars are more than skin deep, and have been shown to cause high levels of anxiety and self-consciousness.8 In an independent study 92% of people said if their acne scars were healed, it would restore or improve their self-confidence. Now with Bellafill®, acne scar sufferers have a new treatment choice, approved by the FDA, that is proven to be safe and effective with minimal to no downtime.
In the U.S., Bellafill® is also approved for the correction of nasolabial folds (NLFs) or smile lines, and is proven effective through 5 years.
Bellafill® received FDA approval for the correction of moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years in December 2014.
Bellafill® was FDA approved in October 2006 (under the name ArteFill®) for treating nasolabial folds (smile lines). In December 2014, Bellafill® was approved by the FDA for the correction of atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years.
Bellafill® is manufactured and distributed by Suneva Medical in the U.S. and Canada.
Schedule your consultation at Pacific Plastic Surgery Center in San Francisco, where we pride ourselves on our results and quality patient experience.
77 Van Ness Ave, Suite 302, San Francisco, CA